Atlas of PET/CT - A Quick Guide to Image Interpretation
β Scribed by Stefano Fanti, Mohsen Farsad, Luigi Mansi (auth.)
- Publisher
- Springer Berlin Heidelberg
- Year
- 2009
- Tongue
- English
- Leaves
- 274
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
This user-friendly atlas, featuring about 500 images, should be a quick guide to interpreting PET/CT images with FDG in oncology. It also illustrates how to recognize normal, para-physiological, and benign pathological uptakes in a case-based practical manner. The text, which includes most relevant technical and pathophysiological premises, covers the main clinical applications and clearly articulates learning points and pitfalls. This atlas aims to become a standard text for nuclear medicine physicians and radiologists, residents and technicians whose work involves PET/CT imaging. This book is also suitable for both undergraduate and postgraduate courses.
β¦ Table of Contents
Front Matter....Pages I-VII
Normal Distribution of FDG....Pages 1-23
Contrast-Enhanced CT in PET-CT (PET-CECT)....Pages 25-39
Pitfalls in FDG PET-CT....Pages 41-105
PET-CT in Oncology....Pages 107-286
Back Matter....Pages 287-288
β¦ Subjects
Nuclear Medicine; Imaging / Radiology; Oncology; Radiotherapy; Hematology
π SIMILAR VOLUMES
<p><p>This new atlas, the fourth of a successful series, is a completely revised and updated edition of a previously published FDG PET-CT atlas. In the past few years, considerable progress has been made in the field of PET-CT imaging, and this new edition takes full account of these recent developm
<p><P>Although [<SUP>18</SUP>F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaining widespread acceptance not only in research
<p><P>Although [<SUP>18</SUP>F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaining widespread acceptance not only in research
<p>This atlas is a case-based guide to the interpretation of FDG PET-CT images in clinical scenarios faced by physicians during the routine practice of oncology. The book aims to help the practitioner to overcome diagnostic dilemmas through familiarization with the physiologic distribution of FDG, n